World Journal of Oncology

Editor-in-Chief
Michael G Martin, MD, Associate Professor of Medicine, Medical Oncologist, West Cancer Center, University of Tennessee, USA Read more...

Frequency: Bimonthly
Journal Access: Open Access
ISSN-print: 1920-4531
ISSN-online: 1920-454X
Indexed and covered: PubMed, PubMed Central, Scopus, Elsevier Embase, Web of Science (ESCI), Chemical Abstract (CA), EBSCO, Worldcat, JournalTOCs, Google, Google Scholar.
Journal archiving and digital preservation: Portico

Combat the COVID-19

Let's Combat COVID-19 Pandemic Together
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers. The Elmer Press Inc is herein to participate the combating COVID-19 through all possible efforts, as a clinical medicine publisher, we would facilitate the rapid and effective communication of management of this pandemic, we will consider submissions related to all aspects of this disease, including prevention, basic viral research, epidemiology, treatment, vaccine, fast screening, diagnosis, prognosis, etc. We will process such manuscripts in priority and publish them ASAP after peer-reviewed and accepted.

Highlights

Recent Advances in the Management of Smoldering Multiple Myeloma
There is remarkable progress in the treatment of multiple myeloma (MM) with significant improvement in survival in the past 10 years. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) can evolve into symptomatic multiple myeloma (sy-MM) with organ involvement.
Read More >>
Fluorescence Emitted by Papanicolaou-Stained Urothelial Cells Improves Sensitivity of Urinary Conventional Cytology for Detection of Urothelial Tumors
Urinary conventional cytology (UCCy) is easy to perform, but its low sensitivity, especially for low-grade urothelial neoplasms (LGUNs), limits its indications in the management of patients at risk of bladder cancer.
Read More >>
Morphology of Tissue Disruption at Sites of High-Grade Tumors
Invasive solid cancers originating from diverse organs like breast, ovary and lung metastasize to distant sites. The structural changes at the primary sites of these high-grade tumors have not been well characterized. The main aim of the current study was to examine if there is any morphological overlap of metastasizing tissues of different invasive tumors.
Read More >>
Epidemiology of Renal Cell Carcinoma
TThough renal cell carcinoma (RCC) accounts for 2% of global cancer diagnoses and deaths, it has more than doubled in incidence in the developed world over the past half-century, and today is the ninth most common neoplasm in the United States (US).
Read More >>
Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer
This study aimed to investigate the association of computed tomography (CT)-assessed sarcopenia and visceral adiposity with efficacy and prognosis of immune-checkpoint inhibitor (ICI) therapy for pretreated non-small cell lung cancer (NSCLC).
Read More >>

< >

Viewpoints			Featured
Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors Renal cell carcinoma (RCC) is a common cancer that affects a significant number of patients every year around the world. The presence of sarcomatoid features in these tumors is considered a poor prognostic feature. Full Text			Overexpression of Programmed Death-Ligand 1 Receptor mRNA as an Independent Negative Prognostic Factor for Triple Negative Breast Cancer Triple negative breast cancer (TNBC) (represents roughly 25% of all breast cancers in Yogyakarta) still has the worst survival compared to other breast cancer subtypes. Results from recent studies have shown that inhibition of programmed death-ligand 1 receptor (PD-L1) in TNBC patients is associated with better prognosis. Full Text

Special Issue

COVID-19 in Cancer Patients
COVID-19 has presented novel challenges to health care systems across the world. We at the World Journal of Oncology would like to take a deeper dive into the interaction of COVID-19 and cancer patients across the world. Specifically we are soliciting articles from authors in low income countries. Topics may include any aspects of COVID-19 in patients with malignancies.
Submission for this special issue with be accepted through January 1st, 2021 with publication expected on March 1st , 2021. All author fees will be reduced by 50% for this issue. Submit your manuscript via online system or email. Feel free to contact us if you have any questions.
Michael G Martin, MD, Editor-in-Chief

Image of the Issue

The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab
Angioimmunoblastic T-cell lymphoma (AITL) is one of the most common types of T cell lymphomas, representing approximately 15-20% of all cases. The CC chemokine receptor 4 (CCR4) is a transmembrane chemokine receptor that plays an important role in the homing and migration of T-cells to the skin, and its expression has been seen in patients with cutaneous T cell lymphomas (CTCL) and adult T-cell lymphomas (ATL). Full Text

Current Issue

Vol. 11, No. 5, Oct 2020

Review

Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors	Abstract HTML PDF
Ragia Aly, Amandeep S. Aujla, Sachin Gupta, Ruby Gupta, Sorab Gupta, Sheila Kalathil	183-187
doi: https://doi.org/10.14740/wjon1325

Original Article

Clinicopathologic Features and Survival Trends for Acinic Cell Carcinoma of the Major Salivary Glands: A Surveillance, Epidemiology, and End Results Population Analysis	Abstract HTML PDF
Erin A. Kaya, Zachary C. Taylor, Brian J. Mitchell, Zachary D. Guss, Jeffrey D. Bunn, Robert K. Fairbanks, Wayne T. Lamoreaux, Aaron E. Wagner, Ben J. Peressini, Christopher M. Lee	188-196
doi: https://doi.org/10.14740/wjon1312

Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial	Abstract HTML PDF
Takanori Kin, Shoichiro Ohtani, Reina Maeda, Ayako Ueno, Miwa Fujihara, Yuri Takamatsu, Yukiko Kajiwara, Mitsuya Ito, Kensuke Kawasaki, Keisuke Abe, Yasuhiko Sakata, Koichi Hiraki	197-203
doi: https://doi.org/10.14740/wjon1333

Fluorescence Emitted by Papanicolaou-Stained Urothelial Cells Improves Sensitivity of Urinary Conventional Cytology for Detection of Urothelial Tumors	Abstract HTML PDF
Kinan Drak Alsibai, Ghislaine Daste, Sophie Ferlicot, Monique Fabre, Karine Steenkeste, Julia Salleron, Yacine Hammoudi, Marie-Pierre Fontaine-Aupart, Pascal Eschwege	204-215
doi: https://doi.org/10.14740/wjon1305

Overexpression of Programmed Death-Ligand 1 Receptor mRNA as an Independent Negative Prognostic Factor for Triple Negative Breast Cancer	Abstract HTML PDF Suppl1
Ibnu Purwanto, Didik Setyo Heriyanto, Ahmad Ghozali, Irianiwati Widodo, Iwan Dwiprahasto, Teguh Aryandono, Sofia Mubarika Haryana	216-222
doi: https://doi.org/10.14740/wjon1302

QUICK LINKS
	Instructions to Authors
	Submit Manuscript
	Editorial Board
	Publication Ethics
	Human & Animal Rights
	Informed Consent
	Conflict of Interest
	Copyright and Permission
	Journal Contact
	Publishing Charge

Journals | Policy | Permission

World Journal of Oncology